259 related articles for article (PubMed ID: 27013545)
1. Minireview: Clinical severity in sickle cell disease: the challenges of definition and prognostication.
Quinn CT
Exp Biol Med (Maywood); 2016 Apr; 241(7):679-88. PubMed ID: 27013545
[TBL] [Abstract][Full Text] [Related]
2. Minireview: Genetic basis of heterogeneity and severity in sickle cell disease.
Habara A; Steinberg MH
Exp Biol Med (Maywood); 2016 Apr; 241(7):689-96. PubMed ID: 26936084
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress status, clinical outcome, and β-globin gene cluster haplotypes in pediatric patients with sickle cell disease.
Rusanova I; Escames G; Cossio G; de Borace RG; Moreno B; Chahboune M; López LC; Díez T; Acuña-Castroviejo D
Eur J Haematol; 2010 Dec; 85(6):529-37. PubMed ID: 20846340
[TBL] [Abstract][Full Text] [Related]
4. Beta-globin gene cluster haplotypes in Yemeni children with sickle cell disease.
Al-Saqladi AW; Brabin BJ; Bin-Gadeem HA; Kanhai WA; Phylipsen M; Harteveld CL
Acta Haematol; 2010; 123(3):182-5. PubMed ID: 20224271
[No Abstract] [Full Text] [Related]
5. Minireview: Prognostic factors and the response to hydroxurea treatment in sickle cell disease.
Wang WC
Exp Biol Med (Maywood); 2016 Apr; 241(7):730-6. PubMed ID: 27026724
[TBL] [Abstract][Full Text] [Related]
6. Predicting clinical severity in sickle cell anaemia.
Steinberg MH
Br J Haematol; 2005 May; 129(4):465-81. PubMed ID: 15877729
[TBL] [Abstract][Full Text] [Related]
7. A systematic review of the literature for severity predictors in children with sickle cell anemia.
Meier ER; Fasano RM; Levett PR
Blood Cells Mol Dis; 2017 Jun; 65():86-94. PubMed ID: 28185829
[TBL] [Abstract][Full Text] [Related]
8. What determines severity in sickle-cell disease?
Schechter AN; Bunn HF
N Engl J Med; 1982 Feb; 306(5):295-7. PubMed ID: 6172711
[No Abstract] [Full Text] [Related]
9. Minireview: Multiomic candidate biomarkers for clinical manifestations of sickle cell severity: Early steps to precision medicine.
Goodman SR; Pace BS; Hansen KC; D'alessandro A; Xia Y; Daescu O; Glatt SJ
Exp Biol Med (Maywood); 2016 Apr; 241(7):772-81. PubMed ID: 27022133
[TBL] [Abstract][Full Text] [Related]
10. Beta-S gene cluster haplotypes modulate hematologic and hemorheologic expression in sickle cell anemia. Use in predicting clinical severity.
Powars DR; Meiselman HJ; Fisher TC; Hiti A; Johnson C
Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):55-61. PubMed ID: 7508688
[TBL] [Abstract][Full Text] [Related]
11. Genetic Variation and Sickle Cell Disease Severity: A Systematic Review and Meta-Analysis.
Kirkham JK; Estepp JH; Weiss MJ; Rashkin SR
JAMA Netw Open; 2023 Oct; 6(10):e2337484. PubMed ID: 37851445
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of high performance liquid chromatography (HPLC) pattern and prevalence of beta-thalassaemia trait among sickle cell disease patients in Lagos, Nigeria.
Adeyemo T; Ojewunmi O; Oyetunji A
Pan Afr Med J; 2014; 18():71. PubMed ID: 25400838
[TBL] [Abstract][Full Text] [Related]
13. Sickle cell disease in pregnancy. Obstetric and anesthetic management perspectives.
Rajab KE; Skerman JH
Saudi Med J; 2004 Mar; 25(3):265-76. PubMed ID: 15048161
[TBL] [Abstract][Full Text] [Related]
14. Severity of Brazilian sickle cell disease patients: severity scores and feasibility of the Bayesian network model use.
Belini Junior E; Silva DG; Torres Lde S; Okumura JV; Lobo CL; Bonini-Domingos CR
Blood Cells Mol Dis; 2015 Apr; 54(4):321-7. PubMed ID: 25842370
[TBL] [Abstract][Full Text] [Related]
15. The relationship between fetal hemoglobin and disease severity in children with sickle cell anemia.
Odenheimer DJ; Sarnaik SA; Whitten CF; Rucknagel DL; Sing CF
Am J Med Genet; 1987 Jul; 27(3):525-35. PubMed ID: 2443006
[TBL] [Abstract][Full Text] [Related]
16. Measuring success: utility of biomarkers in sickle cell disease clinical trials and care.
Kalpatthi R; Novelli EM
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):482-492. PubMed ID: 30504349
[TBL] [Abstract][Full Text] [Related]
17. Fetal hemoglobin concentration predicts disease severity in children with sickle cell anemia.
Rucknagel DL; Sarniak SA; Whitten CF; Odenheimer DA
Prog Clin Biol Res; 1987; 251():487-96. PubMed ID: 2448815
[No Abstract] [Full Text] [Related]
18. Study of alpha hemoglobin stabilizing protein expression in patients with β thalassemia and sickle cell anemia and its impact on clinical severity.
Mahmoud HM; Shoeib AA; Abd El Ghany SM; Reda MM; Ragab IA
Blood Cells Mol Dis; 2015 Dec; 55(4):358-62. PubMed ID: 26460260
[TBL] [Abstract][Full Text] [Related]
19. Heritability of fetal hemoglobin, white cell count, and other clinical traits from a sickle cell disease family cohort.
Bao EL; Lareau CA; Brugnara C; Fulcher IR; Barau C; Moutereau S; Habibi A; Badaoui B; Berkenou J; Bartolucci P; Galactéros F; Platt OS; Mahaney M; Sankaran VG
Am J Hematol; 2019 May; 94(5):522-527. PubMed ID: 30680775
[TBL] [Abstract][Full Text] [Related]
20. Severity in phenotypic expression of homozygous sickle cell disease (Hb.SS)--does hypermelanotic or hypomelanotic skin status of affected patients play a role?
Bakare MO
Med Hypotheses; 2011 May; 76(5):673-5. PubMed ID: 21288648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
